Three prime exonuclease I (trex1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced dna damage

Nucleic Acids Research

Volumn 38, Issue 19, 2010, Pages 6418-6432

  Christmann, Markus ^a   Tomicic, Maja T ^a   Aasland, Dorthe ^a   Berdelle, Nicole ^a   Kaina, Bernd ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; EXONUCLEASE; HYDROGEN PEROXIDE; PROTEIN C FOS; PROTEIN C JUN; RNA; THREE PRIME EXONUCLEASE 1; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; GENE INACTIVATION; GENE INDUCTION; GENOTOXICITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; ULTRAVIOLET RADIATION; UPREGULATION; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BENZO(A)PYRENE; CELL LINE; CELL NUCLEUS; DNA DAMAGE; DNA REPLICATION; EXODEOXYRIBONUCLEASES; GENE KNOCKOUT TECHNIQUES; HUMANS; MICE; MUTAGENS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; ULTRAVIOLET RAYS;

EID: 78049369870     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq455     Document Type: Article

References (56)

1. Christmann, M., Tomicic, M.T., Roos, W.P. and Kaina, B. (2003) Mechanisms of human DNA repair: an update. Toxicology, 193, 3-34.
2. Christmann, M., Fritz, G. and Kaina, B. (2007) Induction of DNA repair genes in mammalian cells in response to genotoxic stress. In Lankenan, D.-H. (ed.), Genome Integrity, Facects and Perspectives. Springer, Berlin, pp. 383-398.
3. Adimoolam, S. and Ford, J.M. (2002) p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl Acad. Sci. USA, 99, 12985-2990.
4. Montecucco, A., Savini, E., Biamonti, G., Stefanini, M., Focher, F. and Ciarrocchi, G. (1995) Late induction of human DNA ligase I after UV-C irradiation. Nucleic Acids Res., 23, 962-966.
5. Hwang, B.J., Ford, J.M., Hanawalt, P.C. and Chu, G. (1999) Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl Acad. Sci. USA, 96, 424-428.
6. Yang, J., Chen, Z., Liu, Y., Hickey, R.J. and Malkas, L.H. (2004) Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res., 64, 5597-5607.
7. Christmann, M., Tomicic, M.T., Origer, J. and Kaina, B. (2005) Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibition. Oncogene, 24, 8304-8313.
8. Lackinger, D., Eichhorn, U. and Kaina, B. (2001) Effect of ultraviolet light, methyl methanesulfonate and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking c-Fos, p53 or both. Mutagenesis, 16, 233-241.
9. Hicks, G.G., Egan, S.E., Greenberg, A.H. and Mowat, M. (1991) Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest. Mol. Cell Biol., 11, 1344-1352.
10. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311. Nucleic Acids Research, 2010, Vol. 38, No. 19 6431
11. Seo, Y.R., Fishel, M.L., Amundson, S., Kelley, M.R. and Smith, M.L. (2002) Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene, 21, 731-737.
12. Offer, H., Milyavsky, M., Erez, N., Matas, D., Zurer, I., Harris, C.C. and Rotter, V. (2001) Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene, 20, 581-589.
13. Smith, M.L., Ford, J.M., Hollander, M.C., Bortnick, R.A., Amundson, S.A., Seo, Y.R., Deng, C.X., Hanawalt, P.C. and Fornace, A.J. Jr (2000) p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell Biol., 20, 3705-3714.
14. Tomicic, M.T., Christmann, M. and Kaina, B. (2005) Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway. Apoptosis, 10, 1295-1304.
15. van Dam, H. and Castellazzi, M. (2001) Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene, 20, 2453-2464.
16. Buscher, M., Rahmsdorf, H.J., Litfin, M., Karin, M. and Herrlich, P. (1988) Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene, 3, 301-311.
17. Dosch, J. and Kaina, B. (1996) Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Oncogene, 13, 1927-1935.
18. Hollander, M.C. and Fornace, A.J. Jr (1989) Induction of fos RNA by DNA-damaging agents. Cancer Res., 49, 1687-1692.
19. Haas, S. and Kaina, B. (1995) c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis, 16, 985-991.
20. Kaina, B., Haas, S. and Kappes, H. (1997) A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs. Cancer Res., 57, 2721-2731.
21. Lackinger, D. and Kaina, B. (2000) Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis. Mutat Res., 457, 113-123.
22. Miller, A.D., Curran, T. and Verma, I.M. (1984) c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell, 36, 51-60.
23. Muller, R., Tremblay, J.M., Adamson, E.D. and Verma, I.M. (1983) Tissue and cell type-specific expression of two human c-onc genes. Nature, 304, 454-456.
24. Kataki, A., Sotirianakos, S., Memos, N., Karayiannis, M., Messaris, E., Leandros, E., Manouras, A. and Androulakis, G. (2003) P53 and C-FOS overexpression in patients with thyroid cancer: an immunohistochemical study. Neoplasma, 50, 26-30.
25. Gamberi, G., Benassi, M.S., Bohling, T., Ragazzini, P., Molendini, L., Sollazzo, M.R., Pompetti, F., Merli, M., Magagnoli, G., Balladelli, A. et al. (1998) C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology, 55, 556-563.
26. Moorehead, R.A. and Singh, G. (2000) Influence of the proto-oncogene c-fos on cisplatin sensitivity. Biochem. Pharmacol., 59, 337-345.
27. Funato, T., Ishii, T., Kanbe, M., Scanlon, K.J. and Sasaki, T. (1997) Reversal of cisplatin resistance in vivo by an anti-fos ribozyme. In Vivo, 11, 217-220.
28. Christmann, M., Tomicic, M.T., Origer, J., Aasland, D. and Kaina, B. (2006) c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF. Nucleic Acids Res., 34, 6530-6539.
29. Christmann, M., Tomicic, M.T., Aasland, D. and Kaina, B. (2007) A role for UV-light-induced c-Fos: stimulation of nucleotide excision repair and protection against sustained JNK activation and apoptosis. Carcinogenesis, 28, 183-190.
30. Platt, K. and Oesch, F. (1983) Efficient synthesis of non-K-region trans-dihydro diols of polycyclic aromatic hydrocarbons from o-quinones and catechols. J. Org. Chem., 48, 265-268.
31. Yagi, H., Thakker, D.R., Hernandez, O., Koreeda, M. and Jerina, D.M. (1977) Synthesis and reactions of the highly mutagenic 7, 8-diol 9, 10-epoxides of the carcinogen benzo[a]pyrene. J. Am. Chem. Soc., 99, 1604-1611.
32. Christmann, M., Tomicic, M.T. and Kaina, B. (2002) Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutS{alpha} mismatch-binding activity. Nucleic Acids. Res., 30, 1959-1966.
33. Tomicic, M.T., Bey, E., Wutzler, P., Thust, R. and Kaina, B. (2002) Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir. Mutat. Res., 505, 1-11.
34. Tomicic, M.T., Friedrichs, C., Christmann, M., Wutzler, P., Thust, R. and Kaina, B. (2003) Apoptosis induced by (E)-5-(2-bromovinyl)- 2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8. Mol. Pharmacol., 63, 439-449.
35. Christmann, M. and Kaina, B. (2000) Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents. J. Biol. Chem., 275, 36256-36262.
36. Yang, Y.G., Lindahl, T. and Barnes, D.E. (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell, 131, 873-886.
37. Harper, J.W. and Elledge, S.J. (2007) The DNA damage response: ten years after. Mol. Cell, 28, 739-745.
38. Bartek, J., Bartkova, J. and Lukas, J. (2007) DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene, 26, 7773-7779.
39. Mazur, D.J. and Perrino, F.W. (1999) Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'->5' exonucleases. J. Biol. Chem., 274, 19655-19660.
40. 0 exonucleases. Characterization of the recombinant proteins. J. Biol. Chem., 276, 17022-17029.
41. 0 DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet., 38, 917-920.
42. Rice, G., Newman, W.G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O'Hara, A. et al. (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am. J. Hum. Genet., 80, 811-815.
43. 0 DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet., 39, 1068-1070.
44. Lee-Kirsch, M.A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.A., de Silva, U., Bailey, S.L., Witte, T., Vyse, T.J. et al. (2007) Mutations in the gene encoding the 30-50 DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet., 39, 1065-1067.
45. Lee-Kirsch, M.A., Chowdhury, D., Harvey, S., Gong, M., Senenko, L., Engel, K., Pfeiffer, C., Hollis, T., Gahr, M., Perrino, F.W. et al. (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med., 85, 531-537.
46. Morita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T. and Barnes, D.E. (2004) Gene-targeted mice lacking the Trex1 (DNase III) 3'->5' DNA exonuclease develop inflammatory myocarditis. Mol. Cell Biol., 24, 6719-6727.
47. Chowdhury, D., Beresford, P.J., Zhu, P., Zhang, D., Sung, J.S., Demple, B., Perrino, F.W. and Lieberman, J. (2006) The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol. Cell, 23, 133-142.
48. Wang, C.J., Lam, W., Bussom, S., Chang, H.M. and Cheng, Y.C. (2009) TREX1 acts in degrading damaged DNA from drug-treated tumor cells. DNA Repair (Amst.), 8, 1179-1189.
49. Stetson, D.B., Ko, J.S., Heidmann, T. and Medzhitov, R. (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell, 134, 587-598.
50. Fritz, G., Tano, K., Mitra, S. and Kaina, B. (1991) Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Mol. Cell. Biol., 11, 4660-4668.
51. Mazur, D.J. and Perrino, F.W. (2001) Structure and expression of the TREX1 and TREX2 30 -> 50 exonuclease genes. J. Biol. Chem., 276, 14718-14727.
52. Lindahl, T., Gally, J.A. and Edelman, G.M. (1969) Properties of deoxyribonuclease 3 from mammalian tissues. J. Biol. Chem., 244, 5014-5019.
53. Hoss, M., Robins, P., Naven, T.J., Pappin, D.J., Sgouros, J. and Lindahl, T. (1999) A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J., 18, 3868-3875.
54. Dunkern, T.R. and Kaina, B. (2002) Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamster cells. Mol. Biol. Cell., 13, 348-361.
55. Milde-Langosch, K. (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer, 41, 2449-2461.
56. Durchdewald, M., Angel, P. and Hess, J. (2009) The transcription factor Fos: a Janus-type regulator in health and disease. Histol. Histopathol., 24, 1451-1461.